In this Issue:
Unrelated UCB transplant for ALL in CR1/2
Stem cell source for SCT in mature lymphoid malignancies after RIC
UCB transplant from unrelated donors in Ph+ ALL
Deep MR achieved quickly with optimised high-dose imatinib
MMR loss as trigger for restarting tyrosine kinase inhibitor in CML
Dasatinib vs. imatinib among Japanese DASISION participants
Declining TRM rates in AML treated with intense induction
Epigenetics meets genetics in AML
Postremission allogeneic SCT vs. chemotherapy in AML
Please login below to download this issue (PDF)